Critical Needs in Advancing Shigella Vaccines for Global Health

Advancing new O-antigen-based Shigella vaccines is critically dependent on development of an international standard serum and harmonized ELISA, demonstration of field efficacy in young children in low- and middle-income countries, and early engagement with regulators and policy makers.

Detalles Bibliográficos
Autores principales: MacLennan, Calman A, Talaat, Kawsar R, Kaminski, Robert W, Cohen, Dani, Riddle, Mark S, Giersing, Birgitte K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071279/
https://www.ncbi.nlm.nih.gov/pubmed/34558631
http://dx.doi.org/10.1093/infdis/jiab462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071279/
https://www.ncbi.nlm.nih.gov/pubmed/34558631
http://dx.doi.org/10.1093/infdis/jiab462

Ejemplares similares